Search

everythinglearnresearchcommunity

for

Search:↓

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Tongue cancer cells show more plectin-1 than non-cancer cells, but both have similar levels of trichohyalin.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Ficus carica leaf extract may help treat melanoma by promoting cancer cell death without harming normal cells.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Male pattern baldness does not cause an increased risk of prostate cancer.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

The new microscope method helps study energy from pre-cancerous skin cells.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

CT scans can find serious prostate cancer even when PSA levels are low.

Cedrol may be an effective treatment for colorectal cancer.

Older men and those with outdoor jobs are at higher risk for skin cancer; early full-body skin checks are recommended for early detection.

Spironolactone does not increase the risk of breast cancer recurrence.